VEGFA and neoplasm: Interestingly, for Zibara and Volk2011a, although the anti-VEGF treatment does not significantly reduce tumour growth and therefore does not yield a better survival estimate for the treated groups compared to their control groups (figures 2b,e and 4b,e), the stratified groups yield significantly different survival estimates.